QA: ENZO Biochem INC in us_health_services/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000316253_2016_ENZO_Biochem_INC.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.008121497604158206, 'aggregate_val': 24826000, 'exp_sum': 24626000, 'exp_to_value': {'LongTermLiabilities': 774000, 'LiabilitiesCurrent': 23852000, 'remainder_Liabilities': 0}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.006708702984089742, 'aggregate_val': 27461000, 'exp_sum': 27278000, 'exp_to_value': {'LongTermLiabilities': 2313000, 'LiabilitiesCurrent': 24965000, 'remainder_Liabilities': 0}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000316253, ENZO Biochem INC

  xvar xval
0 IntangibleAssets 13,607,000
1 AssetsNonCurrent 353,000
2 AssetsCurrent 46,486,000
3 PropertyPlantAndEquipment 7,948,000
4 remainder_Assets 0
5 LongTermLiabilities 1,793,000
6 LiabilitiesCurrent 23,958,000
7 remainder_Liabilities 37,000
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 0
10 GeneralAndAdministrativeExpense 41,069,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 0
15 ResearchAndDevelopmentExpense 3,350,000
16 remainder_Expenses 54,379,000
17 remainder_Revenues 97,599,000
18 remainder_NetIncome -1,086,000
19 remainder_ComprehensiveNetIncome 117,000
  yvar yval
0 Assets 68,394,000
1 Liabilities 25,788,000
2 Expenses 98,798,000
3 Revenues 97,599,000
4 StockholdersEquity 42,606,000
5 NetIncome -2,285,000
6 ComprehensiveNetIncome -2,168,000
7 BaseVar 145,891,000
8 EconomicCapitalRatio 2.47

Edgar->Model Mapping

Feature Distribution

Change over Time